Next Article in Journal
Postprandial Metabolic Responses When Manipulating Timing and Composition of a Meal
Previous Article in Journal
Thermophysical Characterization of Two DyethylMethylAmmonium Ionic Liquids
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Proceedings
Volume 9
Issue 1
10.3390/ecsoc-22-05874
proceedings-logo
Submit to this Journal
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Design and Synthesis of Novel Chalcone-Phenylpyranone Derivatives as Estrogen Receptor Modulators †

by
Pritam N. Dube
1,*,
Yogita B. Thombare
2 and
Vivekanand A. Chatpalliwar
1
1
Department of Pharmaceutical Chemistry, SNJB’s SSD Jain College of Pharmacy, Neminagar, Chandwad, Nashik 423101, Maharashtra, India
2
Department of Pharmaceutical Chemistry, MET Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nashik 422003, Maharashtra, India
*
Author to whom correspondence should be addressed.
†
Presented at the 22nd International Electronic Conference on Synthetic Organic Chemistry, 15 November–15 December 2018; Available Online: https://sciforum.net/conference/ecsoc-22.
Proceedings 2019, 9(1), 30; https://doi.org/10.3390/ecsoc-22-05874
Published: 23 November 2018
(This article belongs to the Proceedings of 22nd International Electronic Conference on Synthetic Organic Chemistry)
Versions Notes

Abstract

Selective estrogen receptor modulators (SERMs) are a class of drugs that act on the estrogen receptor (ER). SERMs are used for treatment and reduction of risk of breast cancer. Herewith we had designed, synthesized, and evaluated chalcone-phenylpyran-2-one derivatives bearing a N,N-dimethyl ethylamine side chain for their anti-breast cancer activity on MCF-7 and Zr-75-1 cell lines in-vitro. The pharmacological data indicated that most of tested compounds showed moderate to significant cytotoxicity and high selectivity toward the estrogen receptor. The Structure activity relationaship analyses indicated that compounds 5f with 2,6-dichloro substitution was more effective. Docking study was performed to predict binding orientation towards the estrogen receptor-α.
Keywords: breast cancer; chalcone; docking; MCF-7; phenylpyranone; SERM breast cancer; chalcone; docking; MCF-7; phenylpyranone; SERM

Share and Cite

MDPI and ACS Style

Dube, P.N.; Thombare, Y.B.; Chatpalliwar, V.A. Design and Synthesis of Novel Chalcone-Phenylpyranone Derivatives as Estrogen Receptor Modulators. Proceedings 2019, 9, 30. https://doi.org/10.3390/ecsoc-22-05874

AMA Style

Dube PN, Thombare YB, Chatpalliwar VA. Design and Synthesis of Novel Chalcone-Phenylpyranone Derivatives as Estrogen Receptor Modulators. Proceedings. 2019; 9(1):30. https://doi.org/10.3390/ecsoc-22-05874

Chicago/Turabian Style

Dube, Pritam N., Yogita B. Thombare, and Vivekanand A. Chatpalliwar. 2019. "Design and Synthesis of Novel Chalcone-Phenylpyranone Derivatives as Estrogen Receptor Modulators" Proceedings 9, no. 1: 30. https://doi.org/10.3390/ecsoc-22-05874

APA Style

Dube, P. N., Thombare, Y. B., & Chatpalliwar, V. A. (2019). Design and Synthesis of Novel Chalcone-Phenylpyranone Derivatives as Estrogen Receptor Modulators. Proceedings, 9(1), 30. https://doi.org/10.3390/ecsoc-22-05874

Article Metrics

Back to TopTop